Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study of Sibutramine in Overweight Adolescents to Assess Weight Loss and Safety.

This study has been completed.
Information provided by:
Abbott Identifier:
First received: December 2, 2005
Last updated: August 30, 2007
Last verified: August 2007